Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05499728 · ClinicalTrials.gov registry record · NA

Telerehabilitation After Shoulder Arthroplasty

A NA study of Rotator Cuff Tear Arthropathy and Arthritis Shoulder Glenohumoral Joint, sponsored by University of Iowa.

Active
Registry status
NA
Development phase
93
Enrollment target
1
Study location

NCT05499728 is a NA study of Rotator Cuff Tear Arthropathy and Arthritis Shoulder Glenohumoral Joint that is active but no longer recruiting, run by University of Iowa. The registered enrollment target is 93 participants, below the 3,446-participant average among 6 other Rotator Cuff Tear Arthropathy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05499728, a NA study of Rotator Cuff Tear Arthropathy and Arthritis Shoulder Glenohumoral Joint, is active but no longer recruiting, sponsored by University of Iowa.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
93 participants
Enrollment target
1
Study location

Study Summary

The use of reverse total shoulder arthroplasty (RSA) has increased dramatically in the United States in recent years. The importance of postoperative physical therapy in the setting of anatomic total shoulder is well understood and explored in the literature. The literature describing postoperative physical therapy for RSA, however, is scarce and somewhat limited to the field of physiatry in the form of clinical commentary on rehabilitation programs.In addition, the use of formal in-person therapy versus physician-guided home therapy has been explored in total shoulder arthroplasty, demonstrating similar post-operative range of motion and patient-reported outcome (PROs) between groups. Furthermore, previous research into "telerehabilitation" or remote physical therapy through a video-based platform has demonstrated noninferiority in outcomes in multiple orthopedic procedures, including hip and knee arthroplasty and reverse shoulder arthroplasty. Telehealth therapy has not yet been formally evaluated in a randomized approach for reverse or anatomic total shoulder arthroplasty. Given the ongoing COVID-19 pandemic, emphasis on social distancing, and multiple states having issued "stay at home" orders, a study into the effectiveness of telerehabilitation on current postoperative outcomes in shoulder arthroplasty may influence postoperative management and allow patients an alternative route for rehabilitation that allows more flexibility in completing, as well as limits potentially extraneous travel and exposure. The project will be a randomized control trial evaluating formal in-person physical therapy versus telerehabilitation after shoulder arthroplasty. Patients who undergo shoulder arthroplasty will complete either formal physical therapy or telerehabilitation postoperatively. The aim will be to identify any differences in shoulder range of motion, pain, or patient-reported outcome measures (PROs) between those who complete in-person physical therapy versus telereha

Interventions

  • OTHER Telerehabilitation; physical therapy via telecommunication device (i.e. online video conferencing)

Study Locations (1)

Iowa

  • Brendan Patterson - Iowa City

Trial Details

FieldValue
Enrollment Target 93 participants
Start Date 2021-08-18
Est. Completion 2025-08-31
Phase NA

Sponsor

University of Iowa

228 total trials

What the Registry Record Tells You About NCT05499728

The ClinicalTrials.gov registry entry for NCT05499728 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,446-participant average among 6 other Rotator Cuff Tear Arthropathy trials with a reported enrollment target (97% lower). The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Rotator Cuff Tear Arthropathy appearing as the primary indexed condition, and to 1 intervention - of which Telerehabilitation; physical therapy via telecommunication device (i.e. online video conferencing) is the first listed.

NCT05499728 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.

Frequently Asked Questions

What is clinical trial NCT05499728 about?

NCT05499728 is a clinical study titled "Telerehabilitation After Shoulder Arthroplasty". The use of reverse total shoulder arthroplasty (RSA) has increased dramatically in the United States in recent years. The importance of postoperative physical therapy in the setting of anatomic total shoulder is well understood and explored in the literature. The literature describing postoperative ...

What is the current status of trial NCT05499728?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 93 participants. The study started on 2021-08-18. Estimated completion is 2025-08-31.

What conditions does trial NCT05499728 study?

This clinical trial studies the following conditions: Rotator Cuff Tear Arthropathy, Arthritis Shoulder Glenohumoral Joint, Arthropathy Shoulder.

What interventions are being tested in trial NCT05499728?

The interventions under investigation include: Telerehabilitation; physical therapy via telecommunication device (i.e. online video conferencing) (OTHER).

Who is sponsoring clinical trial NCT05499728?

This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05499728 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rotator Cuff Tear Arthropathy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.